Guggenheim Capital’s Crinetics Pharmaceuticals CRNX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $817K | Sell |
28,417
-2,424
| -8% | -$69.7K | 0.01% | 955 |
|
|
2025
Q1 | $1.03M | Buy |
30,841
+4,698
| +18% | +$158K | 0.01% | 864 |
|
|
2024
Q4 | $1.34M | Sell |
26,143
-2,019
| -7% | -$103K | 0.01% | 784 |
|
|
2024
Q3 | $1.44M | Sell |
28,162
-287
| -1% | -$14.7K | 0.01% | 949 |
|
|
2024
Q2 | $1.27M | Buy |
28,449
+24,031
| +544% | +$1.08M | 0.01% | 994 |
|
|
2024
Q1 | $207K | Buy |
+4,418
| New | +$207K | ﹤0.01% | 1782 |
|